Ekso Bionics Holdings Inc (EKSO)
1.29
-0.03
(-2.27%)
USD |
NASDAQ |
Apr 22, 16:00
1.26
-0.03
(-2.33%)
After-Hours: 20:00
Ekso Bionics Holdings Revenue (Quarterly): 4.847M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.847M |
| September 30, 2023 | 4.607M |
| June 30, 2023 | 4.703M |
| March 31, 2023 | 4.122M |
| December 31, 2022 | 3.551M |
| September 30, 2022 | 3.329M |
| June 30, 2022 | 3.465M |
| March 31, 2022 | 2.567M |
| December 31, 2021 | 4.076M |
| September 30, 2021 | 3.049M |
| June 30, 2021 | 2.211M |
| March 31, 2021 | 1.91M |
| December 31, 2020 | 2.254M |
| September 30, 2020 | 2.897M |
| June 30, 2020 | 2.264M |
| March 31, 2020 | 1.468M |
| December 31, 2019 | 3.72M |
| September 30, 2019 | 3.319M |
| June 30, 2019 | 3.262M |
| March 31, 2019 | 3.616M |
| Date | Value |
|---|---|
| December 31, 2018 | 3.296M |
| September 30, 2018 | 2.55M |
| June 30, 2018 | 2.967M |
| March 31, 2018 | 2.518M |
| December 31, 2017 | 2.453M |
| September 30, 2017 | 1.597M |
| June 30, 2017 | 1.867M |
| March 31, 2017 | 1.436M |
| December 31, 2016 | 2.587M |
| September 30, 2016 | 1.596M |
| June 30, 2016 | 1.552M |
| March 31, 2016 | 8.486M |
| December 31, 2015 | 1.943M |
| September 30, 2015 | 2.915M |
| June 30, 2015 | 2.114M |
| March 31, 2015 | 1.689M |
| December 31, 2014 | 1.480M |
| September 30, 2014 | 1.588M |
| June 30, 2014 | 1.197M |
| March 31, 2014 | 1.062M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.468M
Minimum
Mar 2020
4.847M
Maximum
Dec 2023
3.243M
Average
3.319M
Median
Sep 2019
Revenue (Quarterly) Benchmarks
| Vicarious Surgical Inc | -- |
| Perspective Therapeutics Inc | -5.239M |
| Xtant Medical Holdings Inc | 28.11M |
| Asensus Surgical Inc | 5.431M |
| Catheter Precision Inc | 0.128M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.214M |
| Total Expenses (Quarterly) | 8.296M |
| EPS Diluted (Quarterly) | -0.22 |
| Enterprise Value | 20.54M |
| Gross Profit Margin (Quarterly) | 48.88% |
| Profit Margin (Quarterly) | -66.31% |
| Earnings Yield | -85.27% |
| Normalized Earnings Yield | -86.85 |